secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aldeyra Therapeutics, Inc. (ALDX)
CIK:        0001341235
Form:       8-K
Filed at:   2026-06-10T00:30:15+00:00
Accession:  0001193125-26-264514
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aldeyra Therapeutics Appoints Darlene Deptula-Hicks as New Director and Audit Committee Chair
--------------------------------------------------------------------------------

- Darlene Deptula-Hicks appointed Class III director and Audit Committee Chair on June 9, 2026.
- Ms. Deptula-Hicks received an option to purchase 94,313 shares vesting over three years.
- Annual meeting ratified BDO USA as auditor; advisory say-on-pay passed.
- Todd C. Brady, M.D., Ph.D., re-elected as director with 23,026,101 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1341235/000119312526264514/0001193125-26-264514-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1341235/000119312526264514/aldx-20260609.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-264514

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer